Fair Prescription Drug Prices for Americans Act caps U.S. drug prices at international average.
The Fair Prescription Drug Prices for Americans Act limits the retail list price of prescription drugs and biological products in the United States to the average price of these products in Canada, France, Germany, Italy, Japan, and the United Kingdom. The Secretary of Health and Human Services calculates this average annually using data from manufacturers and public filings. Manufacturers must submit annual price data for U.S. and international sales. Violators face civil monetary penalties.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.